Imperial/Cell-Free/Whatis
From 2007.igem.org
m |
|||
Line 9: | Line 9: | ||
== Types of Extracts == | == Types of Extracts == | ||
- | |||
+ | {| style="width:800px;" cellpadding="2" cellspacing="0" align="center" | ||
+ | |- style="background:#ffffff; text-align:left;" color:white;" align="center" | ||
+ | || [[Image:Icgems-cellextract.png]] | ||
+ | |style="padding-left:30px;"|''In vitro'' synthesis of proteins using cell-free extracts consists of two main processes - '''transcription''' of DNA into messenger RNA (mRNA) and '''translation''' of mRNA into polypeptides. Coupled transcription-translation systems usually combine a bacteriophage RNA polymerase and promoter (T7, T3, or SP6) with eukaryotic or prokaryotic extracts. In addition, the [http://www.nature.com/nbt/journal/v19/n8/full/nbt0801_732.html PURE] system is a reconstituted CFS for synthesizing proteins using recombinant elements. | ||
+ | |} | ||
+ | <br clear="all"> | ||
'''Comparison between different types of cell extracts''' | '''Comparison between different types of cell extracts''' | ||
- | {| border="1" | + | {| style="width:800px;" cellpadding="2" cellspacing="0" align="center" border="1" |
|- | |- | ||
|style="background:#ffffcc"|<center>Properties</center>||<center>'''Rabbit Reticulocyte Lysate'''</center>||<center>'''Wheat Germ Extract'''</center>||<center>'''''E. coli'' Extract'''</center>||<center>'''Reconstituted Extract'''</center> | |style="background:#ffffcc"|<center>Properties</center>||<center>'''Rabbit Reticulocyte Lysate'''</center>||<center>'''Wheat Germ Extract'''</center>||<center>'''''E. coli'' Extract'''</center>||<center>'''Reconstituted Extract'''</center> | ||
Line 35: | Line 40: | ||
|style="background:#ffffcc"|<center>Post-translational modifications</center>||<center>Yes</center>||<center>Yes</center>||<center>No</center>||<center>Yes</center> | |style="background:#ffffcc"|<center>Post-translational modifications</center>||<center>Yes</center>||<center>Yes</center>||<center>No</center>||<center>Yes</center> | ||
|} | |} | ||
- | + | <br clear="all"> | |
== Types of Compartmentalization == | == Types of Compartmentalization == | ||
Previous research has been done to optimize cell extracts for ''in vitro'' protein synthesis. Their endogenous genetic content is removed so that exogenous DNAs or mRNAs can be expressed. Nuclease activity has been reduced and degradation of certain amino acids has been identified. ATP regenerating systems have also been added to improve the energy supply. Different strategies of compartmentalization have been explored to prolong the lifespan of CFS. | Previous research has been done to optimize cell extracts for ''in vitro'' protein synthesis. Their endogenous genetic content is removed so that exogenous DNAs or mRNAs can be expressed. Nuclease activity has been reduced and degradation of certain amino acids has been identified. ATP regenerating systems have also been added to improve the energy supply. Different strategies of compartmentalization have been explored to prolong the lifespan of CFS. | ||
- | #'''Batch-mode CFS''' | + | {| style="width:800px;" cellpadding="2" cellspacing="0" align="center" |
- | + | |- style="background:#ffffff; text-align:left;" color:white;" align="center" | |
- | #'''Continuous-exchange CFS''' | + | || [[Image:Icgems-bulksol.png|left|200px]] |
- | + | || | |
- | #'''Vesicle-encapsulated CFS''' | + | '''Batch-mode CFS''' |
- | + | *Transcription-translation reaction is carried out in bulk solution. Expression is usually limited by nutrient (nucleotides and amino acids) and energy supplies. | |
+ | |- style="background:#ffffff; text-align:left;" color:white;" align="center" | ||
+ | || [[Image:Icgems-exchange.png|left|200px]] | ||
+ | || | ||
+ | '''Continuous-exchange CFS''' | ||
+ | *Transcription-translation reaction is separated from feeding solution by a dialysis membrane. Expression is sustained by diffusion of nutrients from the feeding soltuion to the reaction. Wastes generated by the reaction is diluted in the feeding solution. | ||
+ | |- style="background:#ffffff; text-align:left;" color:white;" align="center" | ||
+ | || [[Image:Icgems-vesicles.png|left|200px]] | ||
+ | || | ||
+ | '''Vesicle-encapsulated CFS''' | ||
+ | *The reaction is separated from feeding solution by a phospholipid bilayer. Expression is maintained for a longer time period than batch-mode CFS because of exchange of materials between the reaction and the feeding solution across the membrane. More reliable exchange of materials is established by inserting a non-specific pore protein with a suitable channel size into the phospholipid bilayer. | ||
+ | |} | ||
+ | <br clear="all"> |
Revision as of 12:58, 20 October 2007
Introduction
Cell-free systems (CFS) are essentially in vitro translation systems that can have potential advantages over in vivo gene expression when considered in the context of synthetic biology. Two components define the characteristics of these in vitro translation machineries - the kind of cell extract used, as well as the type of compartmentalization that the cell extract is put in.
Together, cell-free systems allow the realization of new potential in simple constructs, as well as the flexibility to functionalize and establish simplistic controls for the system. As the specifications of our projects necessitate a cell-free environment, part of our contributions to iGEM involve the investigation and characterization of cell-free expression systems as a new chassis for the Registry.
Types of Extracts
Comparison between different types of cell extracts
|
|
|
| |
Types of Compartmentalization
Previous research has been done to optimize cell extracts for in vitro protein synthesis. Their endogenous genetic content is removed so that exogenous DNAs or mRNAs can be expressed. Nuclease activity has been reduced and degradation of certain amino acids has been identified. ATP regenerating systems have also been added to improve the energy supply. Different strategies of compartmentalization have been explored to prolong the lifespan of CFS.
Batch-mode CFS
| |
Continuous-exchange CFS
| |
Vesicle-encapsulated CFS
|